Sanguine Biosciences (Sanguine), a leader in connecting patients with biomedical researchers to accelerate precision medicine R&D, this week announced its opening of a blood donor center in Los ...
Blood centers are scaling cell and gene therapies by leveraging decades of expertise in apheresis, logistics, and quality ...
Machine-learning analysis identifies factors predicting T cell collection efficiency in CAR T-cell therapy for DLBCL patients. Higher blood volume, not higher circulating T-cell numbers, correlates ...
The company also welcomes new board member and industry expert Cyrus K. Mirsaidi in furthering Sanguine's mission to integrate patients into the therapeutic research and development process. Human ...
SAN FRANCISCO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Vineti, Inc., the leading software and analytics company for cell and gene therapies, today announced that it will be expanding its technology ...
"This is about starting the data story at the source," said Charles Hutka, Chief Commercial Officer at StafaCT. "When apheresis data is captured directly -- across both collection and therapeutic ...
Dr. Michael Linenberger of Fred Hutchinson Cancer Research Center has been awarded one of the highest honors in the field of apheresis, the medical subspecialty that uses automated methods to separate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results